TABLE 1.

Confidence and Knowledge Outcomes After Workshop Participation

SMV
Non-SMV
Pre-SurveyPost-Survey30-DayPPre-SurveyPost-SurveyP
Immediate Gains 
Confidence* 
Ability to differentiate PK and PD profiles of basal insulins (%) 24 (n = 142) 68 (n = 143) NA <0.001 18 (n = 36) 73 (n = 37) <0.001 
Ability to provide diabetes-related education in an SMV setting (%) 28 (n = 138) 67 (n = 142) NA <0.001 NA NA NA 
Knowledge 
ADA/AACE guideline recommendations for initiating insulin in patients with T2DM (%) 35 (n = 134) 35 (n = 139) NA 0.970 31 (n = 36) 50 (n = 36) 0.012 
PK and PD profiles of basal insulins (%) 61 (n = 136) 76 (n = 139) NA <0.001 49 (n = 35) 64 (n = 36) 0.066 
Management of patients with T2DM using insulin (%) 64 (n = 131) 71 (n = 128)  0.099 77 (n = 35) 89 (n = 27) 0.145 
Understanding SMV (%) 18 (n = 128) 59 (n = 135) NA <0.001 NA NA NA 
Percent correct across three knowledge questions NA NA NA NA 53 (n = 25) 67 (n = 25) 0.030 
Percent correct across four knowledge questions 45 (n = 99) 61 (n = 99) NA <0.001 NA NA NA 
Longer-Term Gains 
Confidence* 
Ability to differentiate PK and PD profiles of basal insulins (%) 25 NA 44 <0.001 NA NA NA 
Ability to provide diabetes-related education in an SMV setting (%) 32 (n = 62) NA 43 (n = 66) <0.001 NA NA NA 
Knowledge 
ADA/AACE guideline recommendations for initiating insulin in patients with T2DM (%) 34 (n = 64) NA 52 (n = 64) 0.003 NA NA NA 
PK and PD profiles of basal insulins (%) 66 (n = 65) NA 86 (n = 65) 0.001 NA NA NA 
Management of patients with T2DM using insulin (%) 70 (n = 59) NA 74 (n = 66) 0.403 NA NA NA 
Understanding SMV (%) 14 (n = 58) NA 41 (n = 66) < 0.001 NA NA NA 
Percent correct across four knowledge questions 46 (n = 56) NA 63 (n = 66) < 0.001 NA NA NA 
SMV
Non-SMV
Pre-SurveyPost-Survey30-DayPPre-SurveyPost-SurveyP
Immediate Gains 
Confidence* 
Ability to differentiate PK and PD profiles of basal insulins (%) 24 (n = 142) 68 (n = 143) NA <0.001 18 (n = 36) 73 (n = 37) <0.001 
Ability to provide diabetes-related education in an SMV setting (%) 28 (n = 138) 67 (n = 142) NA <0.001 NA NA NA 
Knowledge 
ADA/AACE guideline recommendations for initiating insulin in patients with T2DM (%) 35 (n = 134) 35 (n = 139) NA 0.970 31 (n = 36) 50 (n = 36) 0.012 
PK and PD profiles of basal insulins (%) 61 (n = 136) 76 (n = 139) NA <0.001 49 (n = 35) 64 (n = 36) 0.066 
Management of patients with T2DM using insulin (%) 64 (n = 131) 71 (n = 128)  0.099 77 (n = 35) 89 (n = 27) 0.145 
Understanding SMV (%) 18 (n = 128) 59 (n = 135) NA <0.001 NA NA NA 
Percent correct across three knowledge questions NA NA NA NA 53 (n = 25) 67 (n = 25) 0.030 
Percent correct across four knowledge questions 45 (n = 99) 61 (n = 99) NA <0.001 NA NA NA 
Longer-Term Gains 
Confidence* 
Ability to differentiate PK and PD profiles of basal insulins (%) 25 NA 44 <0.001 NA NA NA 
Ability to provide diabetes-related education in an SMV setting (%) 32 (n = 62) NA 43 (n = 66) <0.001 NA NA NA 
Knowledge 
ADA/AACE guideline recommendations for initiating insulin in patients with T2DM (%) 34 (n = 64) NA 52 (n = 64) 0.003 NA NA NA 
PK and PD profiles of basal insulins (%) 66 (n = 65) NA 86 (n = 65) 0.001 NA NA NA 
Management of patients with T2DM using insulin (%) 70 (n = 59) NA 74 (n = 66) 0.403 NA NA NA 
Understanding SMV (%) 14 (n = 58) NA 41 (n = 66) < 0.001 NA NA NA 
Percent correct across four knowledge questions 46 (n = 56) NA 63 (n = 66) < 0.001 NA NA NA 
*

Extremely and moderately confident.

AACE, American Association of Clinical Endocrinologists; ADA, American Diabetes Association; PD, pharmacodynamic; PK, pharmacokinetic; T2DM, type 2 diabetes mellitus.

Close Modal

or Create an Account

Close Modal
Close Modal